These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 22245962)
1. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Stepanova M; Younossi ZM Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962 [TBL] [Abstract][Full Text] [Related]
2. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Pichiri I; Sorgato C; Zenari L; Bonora E J Hepatol; 2010 Oct; 53(4):713-8. PubMed ID: 20619918 [TBL] [Abstract][Full Text] [Related]
4. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Ong JP; Pitts A; Younossi ZM J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038 [TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269 [TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. Zelber-Sagi S; Lotan R; Shibolet O; Webb M; Buch A; Nitzan-Kaluski D; Halpern Z; Santo E; Oren R Liver Int; 2013 Oct; 33(9):1406-12. PubMed ID: 23656177 [TBL] [Abstract][Full Text] [Related]
8. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Kim D; Kim WR; Kim HJ; Therneau TM Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Lazo M; Hernaez R; Eberhardt MS; Bonekamp S; Kamel I; Guallar E; Koteish A; Brancati FL; Clark JM Am J Epidemiol; 2013 Jul; 178(1):38-45. PubMed ID: 23703888 [TBL] [Abstract][Full Text] [Related]
10. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. Pacana T; Fuchs M Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483 [TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients. Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277 [TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. Smits MM; Ioannou GN; Boyko EJ; Utzschneider KM J Gastroenterol Hepatol; 2013 Apr; 28(4):664-70. PubMed ID: 23286209 [TBL] [Abstract][Full Text] [Related]
13. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448 [TBL] [Abstract][Full Text] [Related]
14. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Sung KC; Ryan MC; Wilson AM Atherosclerosis; 2009 Apr; 203(2):581-6. PubMed ID: 18774133 [TBL] [Abstract][Full Text] [Related]
15. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]. Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860 [TBL] [Abstract][Full Text] [Related]
16. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Oni ET; Agatston AS; Blaha MJ; Fialkow J; Cury R; Sposito A; Erbel R; Blankstein R; Feldman T; Al-Mallah MH; Santos RD; Budoff MJ; Nasir K Atherosclerosis; 2013 Oct; 230(2):258-67. PubMed ID: 24075754 [TBL] [Abstract][Full Text] [Related]
17. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? Gianotti G; Cenni A; Bianchi G; Masetti M; Zappoli P; Muscari A; Zoli M; Arch Gerontol Geriatr; 2014; 58(2):188-95. PubMed ID: 24268461 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α. Ajmal MR; Yaccha M; Malik MA; Rabbani MU; Ahmad I; Isalm N; Abdali N Indian Heart J; 2014; 66(6):574-9. PubMed ID: 25634387 [TBL] [Abstract][Full Text] [Related]
19. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879 [TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men. Hwang YC; Ahn HY; Park SW; Park CY Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]